NEW YORK, Nov. 5 Reportlinker.com announces that a new market research report is available in its catalogue.
Cancer Therapeutics: Market Insight & Pipeline Analysis
Advertisement
http://www.reportlinker.com/p0158345/Cancer-Therapeutics-Market-Insight--Pipeline-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire
Advertisement
Objectives and Scope
The intention of this study is to provide a detailed and thorough analysis of the present and future global market for cancer therapeutics. This report analyzes in detail the markets for colorectal cancer, prostate cancer, lung cancer, breast cancer, leukemia and non-Hodgkin's lymphoma. Therapies for other types of cancer are discussed throughout the report, but are limited to the Company Briefs chapter and various tables throughout the report. This report examines these major cancer markets in light of newly emerging therapeutics, shifting market shares and line extensions for major products on the market.
Reason for this study
The overall economic cost of cancer is staggering. The US National Institutes of Health (NIH) estimates overall costs of cancer in the U.S. in 2006 at $206.3 billion with $78.2 billion in direct medical costs. Further the WHO predicts that global cases of cancer will rise to 15 million new cases by 2020, an increase of 50% over 2005's rate. These staggering numbers indicate the importance of effective therapies in treating this epidemic. There is today still a strong need for therapies that more specifically target cancer cells extend progression-free survival rates provide patients with metastatic cancer better treatment options
What questions does this report answer
What is the current market status of cancer therapeutics in general and with regard to specific types of cancer?
What are the strengths, weaknesses, opportunities and threats facing various cancer therapeutics already on the market and ones still in the clinic?
What are the major issues involved in the research and development of more effective cancer therapeutics?
Which new cancer therapeutics in development are nearing the market? And how are they performing in the clinic?
Key features of this Report
Market analysis of cancer therapeutics, by product, class, cancer type, region/country and company
SWOT (strengths, weaknesses, opportunities, threats) analysis for key products on the market as well as for key emerging products
A thorough overview of treatment regimens for various cancers, including detailed information and analysis of first-line, second-line and third-line treatment options
Financial forecasts, by individual cancer therapy and cancer type
Explanations of key technologies and mechanism of action of new classes of cancer drugs
Thorough descriptions of important areas of research and development in cancer therapeutics and cancer vaccines
Focused analysis of the global prevalence of cancer: incidence, mortality and survival rates as they relate to new directions in cancer research
Company briefs of stakeholders and companies active in cancer therapy R&D
Over 145 tables/graphs analyzing the current and future market, disease incidence and R&D pipelines for cancer therapeutics
Presentation and analysis of clinical data underscoring success of key therapies
Market share data for leading companies and products in the field
Profiles of leading products in the major cancer markets and analysis of their market impact
What makes this report topical?
Increasing need for healthcare and pharmaceutical cost-containment in both public and private spheres
Focus on introduction of standards in healthcare
Rising involvement of patients in their own healthcare and rising demand for higher quality care
Increasing use of information technology (IT) in healthcare, which provides easier access to various data and analysis
Large investments in new medical technologies and pharmaceuticals requiring high prices, rendering publicly-funded pharmaceutical reimbursement highly desirable
Unique features of this report
Thorough descriptions of key evidence-based medicine practices in major global medical and pharmaceutical markets
Discussion of evidence-based medicine's future from the point of view of medical advances, not just practical considerations
Analysis of evidence-based medicine from the point of view of pharmaceutical reimbursement
Critical assessment of evidence-based medicine's advantages and disadvantages
To order this report:
Cancer Therapeutics: Market Insight & Pipeline Analysis
http://www.reportlinker.com/p0158345/Cancer-Therapeutics-Market-Insight--Pipeline-Analysis.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire
More market research reports here!
Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker
